Noveris Health Sciences is trading 6.25% up at CA$0.09, with no company-specific announcement identified for September 28, 2026.

  • The company’s latest listed release is its September 9 annual-meeting results.
  • Reuters reported global stocks fell as the U.S.-Iran stalemate lifted oil prices and bond yields, while markets priced in increased odds of another Fed hike.
  • The risk-off backdrop may weigh on sentiment but does not establish the cause of Noveris Health Sciences’ gain.